A shadow economy for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Experts Express Worries
Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users administering substances of unknown origin.
Some experts stated the popularity for retatrutide could be connected to the increasing cost of approved slimming products such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.
Service Reaction and Material Elimination
Based on the social media company, the service has removed problematic content and banned associated keywords and query recommendations. The organization said it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Research also found groups with up to nine thousand members marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of members, filled with photos of slimming results, glowing testimonials and detailed instructions for mixing or injecting at home.
Within moments of joining one community, a seller posted WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or previous experience.
Item Information and Pricing
Within these groups, messages display dark colored parcels with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually priced at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Service Moderation and Security Measures
A representative for Telegram said it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting materials they cannot confirm. Even if the research behind this drug is sound, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.
Her staff has already seen individuals injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject patients to possibly serious health risks”.
